z-logo
open-access-imgOpen Access
Future Perspectives for Cancer Therapy Using the CRISPR Genome Editing Technology
Author(s) -
Noah Isakov
Publication year - 2017
Publication title -
journal of clinical and cellular immunology
Language(s) - English
Resource type - Journals
ISSN - 2155-9899
DOI - 10.4172/2155-9899.1000e120
Subject(s) - crispr , genome editing , cancer , computational biology , genome , medicine , biology , genetics , gene
Over the last two decades, substantial progress has been made in cancer diagnosis and treatment, resulting in a steady improvement in cancer survival. While cancers can be treated using several different protocols, matching a protocol to a patient depends on the type and stage of cancer, in addition to age, sex, race, and the overall health of the patient, as well as considerations relevant to the potential side effects. The most common types of cancer treatment include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and often, combinations of two or more types of the above therapies. However, the rapidly changing field of genome engineering and gene therapy promises a number of new and novel potential strategies for treatment of cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom